Humoral responses to peptides correlate with overall survival in advanced cancer patients vaccinated with peptides based on pre-existing, peptide-specific cellular responses.
Mine T, Sato Y, Noguchi M, Sasatomi T, Gouhara R, Tsuda N, Tanaka S, Shomura H, Katagiri K, Rikimaru T, Shichijo S, Kamura T, Hashimoto T, Shirouzu K, Yamada A, Todo S, Itoh K, Yamana H.
Mine T, et al. Among authors: sato y.
Clin Cancer Res. 2004 Feb 1;10(3):929-37. doi: 10.1158/1078-0432.ccr-1117-3.
Clin Cancer Res. 2004.
PMID: 14871969
Clinical Trial.